Literature DB >> 19447319

Clinical challenges: chemotherapy-induced peripheral neuropathy.

Judith A Paice1.   

Abstract

OBJECTIVES: To discuss the challenges associated with treating pain and altered sensations due to chemotherapy-induced peripheral neuropathy (CIPN). DATA SOURCES: Published research articles and clinical experience.
CONCLUSION: Although there are still great challenges associated with preventing and treating pain and altered sensations due to CIPN, there are preventative strategies and therapeutic options that can certainly improve the quality of life of patients who have cancer. IMPLICATIONS FOR NURSING PRACTICE: Oncology nurses can gain a better understanding of the available pharmacologic and nonpharmacologic strategies that can prevent and reduce pain associated with chemotherapy-induced neuropathy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19447319     DOI: 10.1016/j.soncn.2009.03.013

Source DB:  PubMed          Journal:  Semin Oncol Nurs        ISSN: 0749-2081            Impact factor:   2.315


  19 in total

1.  Impact of peripheral neuropathy induced by platinum in first-line chemotherapy on second-line chemotherapy with paclitaxel for advanced gastric cancer.

Authors:  Ryo Otsuka; Satoru Iwasa; Takako Yanai; Hidekazu Hirano; Hirokazu Shoji; Yoshitaka Honma; Natsuko Okita; Atsuo Takashima; Ken Kato; Hironobu Hashimoto; Masatoshi Sekiguchi; Yoshinori Makino; Narikazu Boku; Masakazu Yamaguchi
Journal:  Int J Clin Oncol       Date:  2019-12-18       Impact factor: 3.402

2.  Patterns and severity of vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemia.

Authors:  Ellen M Lavoie Smith; Lang Li; ChienWei Chiang; Karin Thomas; Raymond J Hutchinson; Elizabeth M Wells; Richard H Ho; Jodi Skiles; Arindom Chakraborty; Celia M Bridges; Jamie Renbarger
Journal:  J Peripher Nerv Syst       Date:  2015-03       Impact factor: 3.494

3.  Assessing patient-reported peripheral neuropathy: the reliability and validity of the European Organization for Research and Treatment of Cancer QLQ-CIPN20 Questionnaire.

Authors:  Ellen M Lavoie Smith; Debra L Barton; Rui Qin; Preston D Steen; Neil K Aaronson; Charles L Loprinzi
Journal:  Qual Life Res       Date:  2013-03-30       Impact factor: 4.147

4.  The prevalence and pattern of chemotherapy-induced peripheral neuropathy among women with breast cancer receiving care in a large community oncology practice.

Authors:  Natalie B Simon; Michael A Danso; Thomas A Alberico; Ethan Basch; Antonia V Bennett
Journal:  Qual Life Res       Date:  2017-06-29       Impact factor: 4.147

Review 5.  Prevention and Management of Chemotherapy-Induced Polyneuropathy.

Authors:  Berit Jordan; Franziska Jahn; Sandra Sauer; Karin Jordan
Journal:  Breast Care (Basel)       Date:  2019-04-10       Impact factor: 2.860

6.  Scope of symptoms and self-management strategies for chemotherapy-induced peripheral neuropathy in breast cancer patients.

Authors:  Rebecca M Speck; Angela DeMichele; John T Farrar; Sean Hennessy; Jun J Mao; Margaret G Stineman; Frances K Barg
Journal:  Support Care Cancer       Date:  2012-01-11       Impact factor: 3.603

7.  The relationship between numbness, tingling, and shooting/burning pain in patients with chemotherapy-induced peripheral neuropathy (CIPN) as measured by the EORTC QLQ-CIPN20 instrument, N06CA.

Authors:  Sherry L Wolf; Debra L Barton; Rui Qin; Edward J Wos; Jeff A Sloan; Heshan Liu; Neil K Aaronson; Daniel V Satele; Bassam I Mattar; Nathan B Green; Charles L Loprinzi
Journal:  Support Care Cancer       Date:  2011-04-12       Impact factor: 3.603

8.  Spinal astrocyte gap junctions contribute to oxaliplatin-induced mechanical hypersensitivity.

Authors:  Seo-Yeon Yoon; Caleb R Robinson; Haijun Zhang; Patrick M Dougherty
Journal:  J Pain       Date:  2013-02       Impact factor: 5.820

9.  Measuring Therapy-Induced Peripheral Neuropathy: Preliminary Development and Validation of the Treatment-Induced Neuropathy Assessment Scale.

Authors:  Tito R Mendoza; Xin Shelley Wang; Loretta A Williams; Qiuling Shi; Elisabeth G Vichaya; Patrick M Dougherty; Sheeba K Thomas; Emre Yucel; Christel C Bastida; Jeanie F Woodruff; Charles S Cleeland
Journal:  J Pain       Date:  2015-07-22       Impact factor: 5.820

10.  Psychometric Testing of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Chemotherapy-Induced Peripheral Neuropathy 20-Item Scale Using Pooled Chemotherapy-Induced Peripheral Neuropathy Outcome Measures Standardization and Alliance for Clinical Trials in Oncology A151408 Study Data.

Authors:  Ellen M Lavoie Smith; Tanima Banerjee; James J Yang; Celia M Bridges; Paola Alberti; Jeff A Sloan; Charles Loprinzi
Journal:  Cancer Nurs       Date:  2019 May/Jun       Impact factor: 2.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.